Femasys Inc. (FEMY) vs Harvard Bioscience, Inc. (HBIO)
Femasys Inc. and Harvard Bioscience, Inc. are both Medical Instruments & Supplies companies. Harvard Bioscience, Inc. is the larger, with a market value of $36.5M against $20.4M — 1.8× the size. Femasys Inc. grew revenue faster over the last twelve months: 21.9% against −1.06%. Harvard Bioscience, Inc. has the higher net margin (−11.9% vs −534.3%) and the higher return on invested capital (−0.41% vs −176.9%). Across the 18 metrics below, Harvard Bioscience, Inc. leads on 10 and Femasys Inc. on 8.
Valuation
Profitability
| Metric | FEMY | HBIO | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 60.95% | 58.16% | 54.62% |
| Operating margin | (763.90%) | (0.28%) | 1.64% |
| Net margin | (534.27%) | (11.86%) | 0.00% |
| Free cash flow margin | (786.02%) | (2.09%) | 1.61% |
| Return on equity | (443.65%) | (89.95%) | 0.00% |
| Return on assets | (94.25%) | (13.32%) | 0.00% |
| Return on invested capital | (176.91%) | (0.41%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack